The pharmacology of purine receptors
Sergeev, P.V.; Shimanovskiĭ, N.L.
Farmakologiia i Toksikologiia 50(1): 115-123
1987
ISSN/ISBN: 0014-8318 PMID: 3549353 Document Number: 304839
Document emailed within 1 workday
Related Documents
Poltavchenko, G.M.; Katkov, V.F.; Pavlov, V.N.; Travkin, O.V. 1990: Binding of adenosine analogs with A1-type purine receptors in the guinea pig ileum Biulleten' Eksperimental'noi Biologii i Meditsiny 109(2): 165-167Forrest, C.M.; Harman, G.; McMillan, R.B.; Stoy, N.; Stone, T.W.; Darlington, L.G. 2005: Modulation of cytokine release by purine receptors in patients with rheumatoid arthritis Clinical and Experimental Rheumatology 23(1): 89-92
Hökfelt, T.; Terenius, L. 1978: Receptor pharmacology (5): Opiate receptors and endorphins Lakartidningen 75(44): 4033-4038
Del Bianco, P.L.; Franchi, G.; Fanciullacci, M.; Sicuteri, F. 1972: Clinical pharmacology of 5-hydroxytryptamine and catecholamines venomotor receptors Archives Internationales de Pharmacodynamie et de Therapie 196: Suppl 196: 113
Teller, M.N.; Giner-Sorolla, A.; Stöhrer, G.; Budinger, J.M.; Brown, G.B. 1978: Oncogenicity of purine 3-oxide and unsubstituted purine in rats Cancer Research 38(8): 2229-2232
Raiteri, M.; Maura, G.; Bonanno, G.; Pittaluga, A. 1986: Differential pharmacology and function of two 5-HT1 receptors modulating transmitter release in rat cerebellum Journal of Pharmacology and Experimental Therapeutics 237(2): 644-648
Cachelin, A.B.; Rust, G. 1994: Unusual pharmacology of (+)-tubocurarine with rat neuronal nicotinic acetylcholine receptors containing beta 4 subunits Molecular Pharmacology 46(6): 1168-1174
Fehmann, H.C.; Arnold, R. 1996: Molecular biology, pharmacology and signal transduction of 5 cloned human somatostatin receptors Zeitschrift für Gastroenterologie 34(11): 767-774
Terán Dávila, J.é; Teppa Garrán, A.D. 2005: Selective estrogen receptors modulators (SERMs): biochemistry, pharmacology, and clinical use in gynecology Ginecologia y Obstetricia de Mexico 73(8): 424-435
Witkowska, M. 1982: Clinical pharmacology of anti-arrhythmia agents. III. Drugs blocking beta adrenergic receptors Kardiologia Polska 25(2): 147-161
Ballerini, P.; Di Iorio, P.; Ciccarelli, R.; Caciagli, F.; Poli, A.; Beraudi, A.; Buccella, S.; D'Alimonte, I.; D'Auro, M.; Nargi, E.; Patricelli, P.; Visini, D.; Traversa, U. 2005: P2Y1 and cysteinyl leukotriene receptors mediate purine and cysteinyl leukotriene co-release in primary cultures of rat microglia International Journal of Immunopathology and Pharmacology 18(2): 255-268
2002: Abstracts, 2nd International Meeting, The platelet ADP receptors: biochemistry, physiology, pharmacology and clinical aspects. 3-5 October 2002, S. Margherita di Pula, Italy Haematologica 87(10 Suppl. 1): 1-30
Tadori, Y.; Kobayashi, H. 2014: The therapeutic plasma concentrations of antiparkinson dopamine agonists and their in vitro pharmacology at dopamine receptors Nihon Shinkei Seishin Yakurigaku Zasshi 34(5-6): 127-132
Panizon, F. 1977: Round table discussion on recent progress in the use of adreno-blocking and adreno-stimulating drugs. Introduction. General concepts concerning the pharmacology and physiopathology of the adrenergic receptors Minerva Pediatrica 29(7): 371-378
Duchêne-Marullaz, P. 1977: Pharmacology, clinical pharmacology and therapeutic effects of Royat's thermal gas Semaine des Hopitaux. Therapeutique 53(7-8): 361-362
Vyas, B. 2001: European Association of Clinical Pharmacology and Therapeutics--Fifth Congress. Clinical pharmacology: from molecule to society--bridging the gap via Man IDrugs: the investigational drugs journal 4(10): 1133-1137
Poulsen, H.Enghusen.; Schmitz, O.E.; Brøsen, K. 2002: Clinical pharmacology 2001--important events. The Danish Society of Clinical Pharmacology Ugeskrift for laeger 164(12): 1652
Barnard, E. 1985: GABAA receptors and opioid receptors as examples of multiple site receptor proteins Alcohol and Drug Research 6(2-3): 63-65
Coutts, S.M.; Nehring, R.E.; Jariwala, N.U. 1980: Purification of rat peritoneal mast cells: occupation of IgE-receptors by IgE prevents loss of the receptors Journal of Immunology 124(5): 2309-2315
Christophe, J.; Waelbroeck, M.; Robberecht, P. 1982: Hormone and neuroeffector receptors in gastroenterology. a concrete example: the VIP (vasoactive intestinal peptide) receptors Acta Gastro-Enterologica Belgica 45(7-8): 280-291